NORGES BANK

Bank

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1374170 OSLO, Q8

Position in MRVI

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,540,576

+$1,579,637 QoQ

Shares Held

567,400

+89.5% QoQ

Ownership

0.219%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 177 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. MRVI ranks #44 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,971,681	$1,476,123,103
2	REGN	Regeneron Pharmaceuticals, Inc.	1,172,808	$731,292,700
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,271,813	$683,883,867
4	BMRN	Biomarin Pharmaceutical Inc	8,207,954	$469,659,127
5	RVMD	Revolution Medicines, Inc.	2,157,479	$404,052,667
6	INSM	INSMED Inc	3,377,641	$360,124,083
7	ARWR	Arrowhead Pharmaceuticals, Inc.	3,896,536	$317,606,649
8	RPRX	Royalty Pharma plc	5,336,084	$299,194,229

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,540,576	567,400	+89.5%	Shares	Sole	2026-08-12
2023-12-31	$1,960,939	299,380	0.0%	Shares	Sole	2024-02-09
2023-09-30	$2,993,800	299,380	-45.4%	Shares	Sole	2024-11-13
2023-06-30	$6,813,330	548,136	-39.3%	Shares	Sole	2024-08-14
2023-03-31	$12,661,677	903,760	-53.8%	Shares	Sole	2024-05-15
2022-12-31	$28,010,379	1,957,399	+42.1%	Shares	Sole	2023-02-14
2022-09-30	$35,168,570	1,377,539	+34.0%	Shares	Sole	2023-11-13
2022-06-30	$29,200,479	1,027,824	+10.3%	Shares	Sole	2023-08-14
2022-03-31	$32,862,081	931,729	0.0%	Shares	Sole	2023-05-12
2021-12-31	$39,039,445	931,729	+11.4%	Shares	Sole	2022-03-09
2021-09-30	$41,059,346	836,580	+34.8%	Shares	Sole	2022-11-14
2021-06-30	$25,905,191	620,781	+701.9%	Shares	Sole	2022-08-15
2020-12-31	$2,171,574	77,418	—	Shares	Sole	2021-03-02
No filing history on record for this holder in this stock.